Cylinder, a virtual digestive health provider, announced its acquisition of Dieta Health, creator of the first clinically validated AI-powered stool imaging app.
Dieta Health developed the world’s first mobile app with clinically-validated AI stool image classification. Traditionally, patients with GI conditions are often asked to observe their stool and report subjective outcomes — like the Bristol Stool Scale — which influences diagnosis and treatment decisions. Dieta’s app allows them to capture stool photos via smartphone, then classifies the stool with 5 clinically-validated data points. The technology has outperformed traditional patient-reported outcomes and has been validated through four peer-reviewed studies, including research from Cedars-Sinai and Mayo Clinic.
Dieta has hundreds of thousands of stool images associated with a diverse set of diagnoses and clinical contexts on individuals. Their efforts have already yielded promising results in areas such as IBS treatment, Ulcerative Colitis monitoring, and Cirrhosis management. Integrating this AI into Cylinder’s platform will provide faster, more accurate insights into GI conditions, enabling earlier diagnoses and tailored treatment plans.
The acquisition also strengthens Cylinder’s clinical partnerships and supports its mission to reduce healthcare costs. The system flags critical shifts in bowel patterns — such as the presence of blood — so the care team can act before complications escalate. By preventing costly hospital stays and streamlining care decisions, these timely interventions also translate into meaningful financial savings for patients and payers.
Cylinder’s digital digestive health platform connects people with individualized, expert-backed care and support for the full spectrum of gastrointestinal issues. By making digestive health support accessible, Cylinder is helping members feel better while reducing absenteeism and healthcare costs for employers. Its individualized care plans go beyond symptom relief, focusing on long-term health outcomes.
Cylinder will be adding Dieta Health’s founder and CEO, Asaf Kraus, along with three key team members to the team, who will continue driving their clinical trial commitment and integrating Dieta’s AI into the core Cylinder platform.
This acquisition aligns with Cylinder’s 2025 growth strategy, offering immediate clinical benefits while providing long-term opportunities to enhance member engagement and outcomes. With a focus on innovation and clinical excellence, Cylinder will continue to lead the future of digestive health.
